KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Divestments (2021 - 2025)

Evolent Health has reported Divestments over the past 5 years, most recently at $198000.0 for Q3 2025.

  • Quarterly results put Divestments at $198000.0 for Q3 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was $198000.0 (up 2728.57% YoY), and the annual figure for FY2025 was $986000.0, up 13985.71%.
  • Divestments for Q3 2025 was $198000.0 at Evolent Health, up from $7000.0 in the prior quarter.
  • Over the last five years, Divestments for EVH hit a ceiling of $43.0 million in Q1 2021 and a floor of -$33.6 million in Q2 2021.
  • Median Divestments over the past 5 years was $786000.0 (2023), compared with a mean of $5.8 million.
  • Peak annual rise in Divestments hit 161.25% in 2022, while the deepest fall reached 487.83% in 2022.
  • Evolent Health's Divestments stood at $28.8 million in 2021, then fell by 6.89% to $26.8 million in 2022, then plummeted by 99.74% to $71000.0 in 2023, then tumbled by 90.14% to $7000.0 in 2024, then skyrocketed by 2728.57% to $198000.0 in 2025.
  • The last three reported values for Divestments were $198000.0 (Q3 2025), $7000.0 (Q2 2024), and $71000.0 (Q3 2023) per Business Quant data.